Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV000759798 | SCV000889370 | uncertain significance | not provided | 2018-01-03 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV001001860 | SCV001159574 | likely benign | not specified | 2018-09-23 | criteria provided, single submitter | clinical testing | The HBB c.394C>A; Gln131Lys variant (rs33910209), commonly known as Hb Shelby, is a stable hemoglobin variant with normal oxygen affinity and has not been associated with any significant clinical symptoms in the heterozygous state or in combination with beta(0)-thalassemia, HbS, or HbC (Lutcher 1976, see link to HbVar and references therein). This variant is reported in ClinVar (Variation ID: 15349), and is absent from general population databases (1000 Genomes Project, Exome Variant Server, and Genome Aggregation Database), indicating it is not a common polymorphism. The glutamine at codon 131 is highly conserved, but computational analyses (SIFT: damaging, PolyPhen-2: benign) predict conflicting effects of this variant on protein structure/function. Based on available information, the Hb Shelby variant is considered to be likely benign. References: Link to HbVar for Hb Shelby: http://globin.bx.psu.edu/cgi-bin/hbvar/query_vars3?mode=output&display_format=page&i=536&.cgifields=histD Lutcher CL et al. Hb Leslie, an unstable hemoglobin due to deletion of glutaminyl residue beta 131 (H9) occurring in association with beta0-thalassemia, HbC, and HbS. Blood. 1976 Jan;47(1):99-112. |
OMIM | RCV000016593 | SCV000036862 | other | HEMOGLOBIN SHELBY | 2017-12-12 | no assertion criteria provided | literature only | |
OMIM | RCV000016594 | SCV000036863 | other | HEMOGLOBIN LESLIE | 2017-12-12 | no assertion criteria provided | literature only | |
OMIM | RCV000016595 | SCV000036864 | other | HEMOGLOBIN DEACONESS | 2017-12-12 | no assertion criteria provided | literature only |